PANZYNORM FORTE 20,000 #30

The drug compensates insufficiency of external secretory function of the pancreas. It is a combined preparation, the action of which is caused by its components.

High lipase activity plays an important role in treatment of maldigestion caused by pancreatic enzyme insufficiency. Lipase breaks down fats by hydrolysis into fatty acids and glycerol, thus promoting their absorption and the absorption of fat-soluble vitamins. Amylase splits carbohydrates into dextrins and sugars, while protease splits proteins. It has a protective coating, due to which active enzymes are released in the small intestine, where pancreatic enzymes act.

Included in pancreatin enzymes lipase, amylase and protease facilitate the digestion of fats, carbohydrates and proteins, which contributes to their more complete absorption in the small intestine.

Moves symptoms caused by poor digestion (a heavy and full stomach, flatulence, shortness of breath, shortness of breath caused by accumulated gas in the intestines and diarrhea). Improves the process of digestion in children; stimulates the release of their own enzymes of the pancreas, stomach and small intestine and bile.